A boost for US stocks amid hopes of vaccine breakthrough
THE vaccine trade is well and truly on, giving the bull market a double jolt of life and volatility.
US stocks gained last week and the Dow Jones Industrial Average completed its strongest opening in the post-World War II era after promising news emerged from a Covid-19 vaccine trial.
With more updates due from vaccine developer Moderna; the US coping with a rapidly building winter wave of novel coronavirus infections and deaths; and the possibility of another round of emergency stimulus, the coming week is sure to see major moves too.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance